Dall'Era M - Search Results

1

Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations.

Askanase AD, Furie RA, Dall'Era M, Bomback AS, Schwarting A, Zhao MH, Bruce IN, Khamashta M, Rubin B, Carroll A, Daniels M, Levy RA, van Vollenhoven R, Urowitz MB. Askanase AD, et al. Lupus Sci Med. 2024 May 22;11(1):e001124. doi: 10.1136/lupus-2023-001124. Lupus Sci Med. 2024. PMID: 38777595 Free PMC article. Review.

2

Systemic lupus erythematosus. How to manage, when to refer.

Dall'Era M, Davis JC. Dall'Era M, et al. Postgrad Med. 2003 Nov;114(5):31-7, 40. doi: 10.3810/pgm.2003.11.1528. Postgrad Med. 2003. PMID: 14650091 Review.

3

CTLA4Ig: a novel inhibitor of costimulation.

Dall'Era M, Davis J. Dall'Era M, et al. Lupus. 2004;13(5):372-6. doi: 10.1191/0961203303lu1029oa. Lupus. 2004. PMID: 15230295 Review.

4

Type I interferon correlates with serological and clinical manifestations of SLE.

Dall'era MC, Cardarelli PM, Preston BT, Witte A, Davis JC Jr. Dall'era MC, et al. Ann Rheum Dis. 2005 Dec;64(12):1692-7. doi: 10.1136/ard.2004.033753. Epub 2005 Apr 20. Ann Rheum Dis. 2005. PMID: 15843451 Free PMC article.

5

Clinical trial design in systemic lupus erythematosus.

Dall'Era M, Wofsy D. Dall'Era M, et al. Curr Opin Rheumatol. 2006 Sep;18(5):476-80. doi: 10.1097/01.bor.0000240357.22680.63. Curr Opin Rheumatol. 2006. PMID: 16896285 Review.

6

A quality indicator set for systemic lupus erythematosus.

Yazdany J, Panopalis P, Gillis JZ, Schmajuk G, MacLean CH, Wofsy D, Yelin E; Systemic Lupus Erythematosus Quality Indicators Project Expert Panels. Yazdany J, et al. Arthritis Rheum. 2009 Mar 15;61(3):370-7. doi: 10.1002/art.24356. Arthritis Rheum. 2009. PMID: 19248127 Free PMC article.

7

Systemic lupus erythematosus clinical trials-an interim analysis.

Dall'Era M, Wofsy D. Dall'Era M, et al. Nat Rev Rheumatol. 2009 Jun;5(6):348-51. doi: 10.1038/nrrheum.2009.79. Nat Rev Rheumatol. 2009. PMID: 19491915 Review.

8

Biologic therapy for systemic lupus erythematosus.

Dall'Era M, Wofsy D. Dall'Era M, et al. Discov Med. 2010 Jan;9(44):20-3. Discov Med. 2010. PMID: 20102681 Free article. Review.

9

Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.

Dall'era M, Chakravarty EF. Dall'era M, et al. Curr Rheumatol Rep. 2011 Aug;13(4):308-16. doi: 10.1007/s11926-011-0186-6. Curr Rheumatol Rep. 2011. PMID: 21584692 Free PMC article. Review.

10

Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Dall'Era M. Dall'Era M. Curr Opin Rheumatol. 2011 Sep;23(5):454-8. doi: 10.1097/BOR.0b013e328349a1e5. Curr Opin Rheumatol. 2011. PMID: 21720247 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters